For: | Yan SY, Fan JG. Application of immune checkpoint inhibitors and microsatellite instability in gastric cancer. World J Gastroenterol 2024; 30(21): 2734-2739 [PMID: 38899328 DOI: 10.3748/wjg.v30.i21.2734] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i21/2734.htm |
Number | Citing Articles |
1 |
Ahmed Reda Bahr, Ahmed Magdy Hassan, Mohamed Wagdy, Mahmoud Abdelkader, Ahmed Samy Elgammal. Efficacy and Safety of Tislelizumab in Combination with Chemotherapy versus Placebo Plus Chemotherapy in Patients with Advanced Gastric Cancer or Gastroesophageal Junction Cancer: A Systematic Review of Randomized Controlled Trials. ASIDE Gastroenterology 2025; 1(2): 16 doi: 10.71079/ASIDE.GI.06052577
|
2 |
Gabriel Samasca, Claudia Burz, Irena Pintea, Adriana Muntean, Diana Deleanu, Iulia Lupan, Vasile Bintintan. A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 Update. Pharmaceuticals 2024; 17(9): 1121 doi: 10.3390/ph17091121
|
3 |
Wenyu Zhang, Jingzheng Chen, Zehao Wei, Jiaqian Song, Xinyi Zha, Deqiang Wang, Min Xu. Advancements and challenges in immunotherapy for gastric cancer: current approaches and future directions. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1592733
|